“Very knowledgeable staff and wonderful receptionists. Excellent care and highly recommended office for anyone seeking professional eye services.”
Diabetic Retinopathy vs. Macular Degeneration: Understanding the Difference
How Vision Loss Differs Between the Two Conditions
Though both conditions can cause serious vision loss, the way that loss develops, where it occurs in the visual field, and how quickly it progresses differs considerably between the two diseases.
Diabetic retinopathy can affect vision in several ways depending on where the damage occurs. In early stages, many people notice no changes at all. As the disease progresses, leaking blood vessels may cause blurry vision or dark spots. A complication called diabetic macular edema, where fluid accumulates in the macula, can blur central vision at any stage of the disease.
In advanced cases, bleeding from fragile new blood vessels can cause sudden floaters, a dark curtain across the vision, or dramatic vision loss. This bleeding, called a vitreous hemorrhage, may clear on its own or may require surgical treatment. Scar tissue from repeated bleeding can pull on the retina and cause it to detach, which is a medical emergency. Because diabetic retinopathy can involve the entire retina, it has the potential to affect both central and peripheral vision.
AMD affects central vision specifically. In the dry form, loss tends to develop gradually. Straight lines may begin to look wavy, or a blurry spot may appear in the center of your visual field. Reading, recognizing faces, and seeing fine detail become progressively harder, while side vision typically stays intact.
In the wet form of AMD, vision loss can occur suddenly, sometimes over days or weeks. This is why any abrupt change in the center of your vision should prompt an urgent visit to your eye care provider. Unlike diabetic retinopathy, AMD does not typically cause widespread peripheral vision loss because the disease remains focused on the macula.
Diabetic retinopathy can remain stable for years with well-managed blood sugar and blood pressure, or it can advance rapidly if those factors are poorly controlled. Pregnancy can also accelerate progression in people with diabetes. With appropriate treatment, many patients maintain useful vision for many years.
Dry AMD typically progresses slowly, sometimes over many years, though it can convert to wet AMD at any point. When that conversion occurs, vision can decline quickly. This risk of conversion is one of the key reasons regular monitoring is so important for anyone with AMD.
How These Conditions Are Detected and Monitored
Both conditions can be present for some time before symptoms become noticeable, which makes regular eye exams essential for early detection and timely treatment.
Diabetic retinopathy is identified during a dilated eye exam, where drops widen the pupils to allow a clear view of the retina. Your provider looks for microaneurysms (tiny bulges in vessel walls), leaking vessels, swelling, and abnormal new vessel growth. Optical coherence tomography (OCT), a scan that captures detailed cross-sections of the retinal layers, is commonly used to detect macular edema.
People with type 2 diabetes should have their first dilated eye exam at the time of diagnosis, since the disease may have been present for years before it was caught. Those with type 1 diabetes should begin screening within five years of their diagnosis. Annual exams are generally recommended after that, though more frequent visits may be advised if changes are detected.
AMD is also identified through a dilated eye exam. Your provider looks for drusen, pigment changes in the macula, and signs of fluid leakage that indicate the wet form. OCT imaging is especially useful for detecting subtle fluid buildup or thinning of the retinal layers that may not be visible to the naked eye.
A simple home monitoring tool called the Amsler grid can help you track changes between appointments. It is a grid of straight lines with a central dot. If the lines appear wavy, distorted, or missing when you focus on the dot, this may signal a change in your macula and should be reported to your eye care provider right away. Anyone over fifty or with a family history of AMD should discuss appropriate screening with their provider.
It is possible to have both diabetic retinopathy and AMD at the same time, particularly in older adults who have had diabetes for many years. When both are present, monitoring becomes more complex because your provider must track changes related to each disease separately. The macula is affected by both conditions, so distinguishing fluid from diabetic macular edema versus fluid from wet AMD requires careful imaging and clinical experience.
Having both conditions does increase the overall risk of vision loss, making consistent and thorough eye exams even more important. Treatment decisions may need to account for both diseases simultaneously.
Treatment Approaches: Similarities and Differences
There is meaningful overlap in how these two conditions are treated, but there are also important distinctions in goals, timing, and approach that your provider will consider carefully.
One significant area of overlap is that both conditions can be treated with injections that target a protein called vascular endothelial growth factor, or VEGF. This protein promotes the growth of abnormal blood vessels and causes fluid leakage from damaged vessels. Blocking VEGF helps reduce fluid buildup, slow abnormal vessel growth, and protect vision.
For diabetic retinopathy and diabetic macular edema, anti-VEGF injections can stabilize or improve vision by reducing swelling in the macula and shrinking abnormal blood vessels. For wet AMD, the same class of medications targets the abnormal vessels growing beneath the macula. While the medication class is shared, the treatment schedule, expected response, and long-term goals differ based on the underlying disease process and how each patient responds over time.
Laser therapy plays a meaningful role in treating diabetic retinopathy. A procedure called panretinal photocoagulation (PRP) applies laser to the outer retina to reduce VEGF production and slow abnormal vessel growth. Focal laser can also be used to seal specific leaking vessels in the macula to reduce fluid associated with diabetic macular edema.
For AMD, laser therapy was once more common in treating the wet form but has largely been replaced by injection therapy, which is more effective and causes less damage to surrounding tissue. Laser is occasionally still used in specific circumstances. For dry AMD, there is currently no laser treatment, though research into potential therapies continues.
Preventing progression differs depending on the condition. For diabetic retinopathy, the most effective steps are controlling blood sugar, blood pressure, and cholesterol. These metabolic factors directly influence how quickly the disease advances. Regular eye exams allow your provider to detect problems early and begin treatment when it is most effective.
For AMD, prevention centers on different factors. Quitting smoking is one of the most impactful steps you can take, as smoking significantly increases the risk of developing AMD and accelerates its progression. A diet rich in leafy green vegetables and fish may help slow progression of dry AMD. A specific nutritional supplement formula studied in clinical research has been shown to reduce the risk of progression in people with intermediate dry AMD. Your provider can advise you on whether this supplement is appropriate for your situation.
Having Both Conditions at the Same Time
Because diabetic retinopathy and AMD are both common, and because they tend to develop in overlapping age groups, some patients are managing both at the same time, which adds complexity to their care.
As people with diabetes live longer, they are more likely to reach the age when AMD typically develops. This means an older adult with long-standing diabetes may have retinal damage from both elevated blood sugar and the aging process at the same time. The two conditions do not cause each other, but they can coexist in the same eye.
When both are present, the combined effect on the retina can make vision management more challenging. Both conditions benefit from early detection, consistent monitoring, and timely treatment. The overall risk to vision is greater when two separate disease processes are affecting the same delicate tissue.
When both conditions are present, your provider works to identify which changes are caused by which disease. Sometimes this is straightforward, as when drusen characteristic of dry AMD are found alongside microaneurysms from diabetic retinopathy. In other cases, distinguishing fluid from diabetic macular edema from fluid caused by wet AMD requires advanced imaging and careful clinical judgment.
Treatment planning for a dual diagnosis typically prioritizes the condition causing the most immediate threat to vision. In some cases, a single anti-VEGF injection can benefit both conditions at once, since both diabetic macular edema and wet AMD respond to that class of therapy. Your provider will tailor the plan to your specific situation, and you may need more frequent monitoring than someone managing only one of these conditions.
If you have diabetes and are over fifty, comprehensive eye exams that evaluate both the peripheral retina and the macula in detail are essential. Your provider should assess the full retina for signs of diabetic retinopathy and examine the macula carefully for changes consistent with AMD. OCT imaging is a valuable tool for assessing both conditions in a single visit.
Report any new vision symptoms promptly, including increased blurriness, new floaters, wavy lines, or a dark spot in your central vision. Do not assume a change is related to one condition and not the other. Let your provider investigate through proper testing. Early intervention is critical for both diseases, and delays can lead to changes that are more difficult to reverse.
Frequently Asked Questions
Here are answers to some of the questions we hear most often from patients navigating these two conditions.
They are separate diseases with different underlying causes and they do not cause or increase the risk of each other. Having a family history of AMD does not raise your risk of diabetic retinopathy, and having diabetes does not make AMD more likely. However, both affect the retina and can occur simultaneously in the same person, which is why a thorough exam must account for both when relevant risk factors are present.
In some cases, yes. When both diabetic macular edema and wet AMD are present, an anti-VEGF injection can address fluid and abnormal vessel activity associated with both. However, this does not mean the two conditions are being treated identically. Your provider monitors the response to each disease separately and adjusts the treatment plan based on which condition is responding, which is progressing, and what your vision needs most at any given time.
You likely cannot determine this on your own, and it would not be safe to try. Both conditions can cause blurry central vision, and both can change gradually or rapidly depending on the stage and form of the disease. Your provider uses OCT imaging, dilated examination, and sometimes fluorescein angiography (a dye-based imaging test) to pinpoint which condition is responsible for specific changes. Report all new or worsening symptoms promptly rather than waiting for your next scheduled visit.
Blood sugar management directly reduces the risk of diabetic retinopathy progressing, but it does not directly slow AMD because AMD is not caused by diabetes or high blood sugar. That said, if you have both conditions, keeping blood sugar well controlled prevents diabetic retinopathy from adding to the retinal stress your eye is already under from AMD. Managing one disease well always benefits your overall retinal health, even when it does not directly treat the other condition.
Yes, having both conditions typically means your provider will want to see you more frequently than someone managing only one. The exact schedule depends on the severity and activity of each disease, how well treatments are working, and any recent changes in your vision. Annual exams are a minimum baseline for people with diabetes, but active or recently changed disease often warrants visits every few months. Following your recommended schedule closely gives your provider the best chance to catch and address changes early.
Yes. Any sudden loss of vision, new curtain or shadow across your visual field, a rapid increase in floaters, or a sudden change in the center of your vision should be treated as urgent and evaluated the same day if possible. In diabetic retinopathy, sudden symptoms can indicate a vitreous hemorrhage or retinal detachment, both of which may require prompt surgical intervention. In wet AMD, sudden central vision loss signals rapid disease activity that responds better to treatment when addressed quickly. Do not wait for a routine appointment if vision changes suddenly.
Expert Retinal Care on the Delmarva Peninsula
At Atlantic Retina Center, our entire focus is the retina, vitreous, and macula, and our team of vitreoretinal specialists brings that depth of expertise to every patient we see. Whether you are managing diabetic retinopathy, macular degeneration, or both, we are here to provide thorough evaluation, precise imaging, and individualized treatment planning. We welcome you to schedule an appointment and experience the difference that single-specialty retinal care can make for your vision and your peace of mind.